+44 (0)844 736 9016     info@mawdsleys.com    LinkedIn

For more information call
+44 (0)844 736 9016
or email us here

Jun 6, 2019

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.

Dec 13, 2018

MPW's brand new warehouse and distribution centre in Doncaster is open for business.

Oct 2, 2018

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.

Jul 26, 2018

Looking for a warehouse solution to ensure you have buffer stock in the UK in the event of a hard Brexit?


Jun 22, 2018

Guy’s and St Thomas’ NHS Foundation Trust in London was looking for efficiencies within its procurement function at Guy’s Hospital.

Apr 25, 2018

The racking is going in!

Mar 28, 2018

Hospitals in Wales can order Europharma lines from Mawdsleys in their normal way:

Mar 27, 2018

Mawdsleys are delighted to be the distribution route to the NHS for Reig Jofre’s CMU contract products.

Hospitals can now order Reig Jofre products from Mawdsleys Wholesale in their normal way:

Feb 23, 2018

Mawdsleys’ hospital customers are already seeing the benefits of the latest developments to their dedicated portal, Mawdsleys Online.

Feb 9, 2018

Check out the latest pictures of our new MPW site

Feb 1, 2018

As a third party logistics provider offering a seamless service to pharmaceutical companies, MPW realises the importance of real-time management data for our clients’ business.

Jan 16, 2018

Your dedicated MPW team.

Nov 14, 2017

As part of our commitment to providing an outstanding service to our clients, MPW (Mawdsleys Pre Wholesale), are delighted to announce the newest additions to our fleet.

Oct 25, 2017

Mawdsleys team up with TENA to provide incontinence training to local pharmacy staff.

Oct 5, 2017

B Braun has chosen Mawdsleys as one of their two distributors to hospitals in England and Wales.

Sep 20, 2017

Mawdsleys will be distributing Strides Pharma UK products to English hospitals as part of CMU contract

Sep 18, 2017

Mawdsleys exhibit at Greater Manchester LPC Pharmacy Conference

Sep 18, 2017

Tillomed Laboratories use Mawdsleys to bring their injectable products to market

Sep 15, 2017

Work is progressing quickly as the structure is now in place of the brand new 150,000 sq ft warehouse currently being built in Yorkshire.

Sep 14, 2017

Mawdsleys are hosting a webinar to help people in the healthcare sector and pharmaceutical industry develop a deeper understanding of Named Patient Programmes.

Jul 24, 2017

Mawdsleys become exclusive distributor of Consilient's new generic Anagrelide.

Apr 13, 2017

Coming soon - Mawdsleys' Pre-Wholesale division to open additional site in Yorkshire

Apr 11, 2017

New app launched to provide offers and retail support to customers

Mar 1, 2017

Neon Healthcare have chosen Mawdsleys as their distributor to hospitals in England for their first CMU contract award.

Dec 15, 2016
Not knowing crucial numbers could be costing you, says Mawdsleys' Omar Shakoor.
Nov 17, 2016
Mawdsleys look to understand the support that hospitals need for the Carter recommendations.
Oct 10, 2016
Sodium Nitrite Injection, Sodium Thiosulfate Injection, and Nithiodote Kits are NOW AVAILABLE in the United Kingdom EXCLUSIVELY from Mawdsleys
Sep 20, 2016
Mawdsleys team up with the UK's number one incontinence brand TENA, to provide in depth training and advice on bladder weakness to local pharmacy staff.
Aug 22, 2016

At Mawdsleys we understand that you need to be preparing your plans for the Carter review under the Hospital Pharmacy Transformation Programme (HPTP), but you might need support and information to get started. We have been consulting with key individuals in hospitals about their Lord Carter plans for some time and have started to supply data such as order frequency reports and audit data to help hospital trusts start planning.

Jul 13, 2016

Innovative and ground-breaking developments have been made within oncology treatment, as the first ever licensed Gemcitabine infusion bags receive regulatory approval. 

Jul 8, 2016

Product shortages have been a problem for pharmacies and other healthcare providers for many years. They can have a significant effect on patients and pharmacies; not to mention the NHS as a whole. 

Jul 6, 2016

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all
medicines and medical devices in the UK, by ensuring they are safe and that those manufacturing,
storing and distributing them are fit to do so. It is compulsory that all UK pharmaceutical manufacturers and distributors undergo a system of licensing and inspection to certify their products are safe, and ensure that they work in compliance with regulatory requirements.

Jun 21, 2016

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. They provide ground-breaking products and services in more than twenty countries around the world. They have more than 100 years of scientific expertise and draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.

Daiichi Sankyo approached Mawdsleys’ Pre-Wholesale (MPW) in January 2016; seeking a flexible, cost effective pre-wholesale distributor, that excelled in efficiency. 

Jun 16, 2016

Survival Pack Update…We are happy to confirm that all of our Pharmacy Cuts Survival Packs have now been packed, sent, signed and delivered to thousands of independent pharmacies across the country. 

May 4, 2016

The impending pharmacy funding cuts is an issue that will impact independent pharmacy the most, making it vital for us to act now! As a company as independent as you are, we at Mawdsleys are here to offer expert advice and support through this challenging time.  

May 3, 2016

As of 1st May 2016, Mawdsleys will become the sole distributor for all Ranbaxy contracted products into the hospital sector (as you are aware, currently hospitals purchase Ranbaxy products directly). All products are now listed on Mawdsleys Online. To ensure continuity of supply all products can still be ordered through Ranbaxy directly until the end of May.   

Mar 14, 2016

Ever thought about selling medicinal products to other pharmacies and wholesalers? Here’s how we can help:

Mar 3, 2016

You may have heard - our customer service number has changed!

Feb 17, 2016

For over a decade, Mawdsleys Pre-Wholesale (MPW) has been supporting pharmaceutical companies by providing warehouse and logistics services. Through the outstanding service provided, MPW has grown significantly, becoming a partner of choice for our clients and their customers, and boasts an unrivalled reputation in the market place. 

Jan 21, 2016

As you will have already heard the Department of Health and NHS England have recently announced a reduction in funding for community pharmacies.


Nov 27, 2015

 Do you monitor your pharmacy’s financial performance? Do you know how to track your pharmacy’s dispensing business and national services? And can you compare these to the performance of other pharmacies in your area?

Nov 4, 2015

Mawdsleys are delighted to be exhibiting at this year’s Healthy Living awards. 

Sep 11, 2015

Following the success of May’s Stepping Up Together conference, the NPA are delighted to announce part two; which will be held at The Manchester Conference Centre on Sunday September 20th; free of charge. 

Jun 12, 2015

The contract wave has come back around and we want to share the work load with all of our customers! At Mawdsleys we believe in working together with our customers to help keep your blood pressure down at this stressful time. 

Jun 10, 2015

Mawdsleys warmly welcomes three new colleagues to support our capability to provide regulatory and pharmaceutical services. Qualified Person (QP) Phil Millward and BDMs Angela McDermott (Clinical Trials Service) and Daniel Belcher (Regulatory and QP Services) all joined the team in May. 

Jun 5, 2015

We are thrilled to announce that Morningside Pharmaceuticals Ltd have nominated us as distributors from 1st July 2015. 

May 29, 2015
To say a big thank you to our loyal OTC customers we are offering you the chance to win an experience of a lifetime. 
May 19, 2015

Eat your heart out Simon Cowell, Mawdsley’s very own pharmaceutical services director Omar Shakoor has been selected by the C+D magazine to judge in this year’s awards.

Apr 7, 2015

Customers can now receive multi level discounts from manufacturers through Mawdsleys as well as an extra 2% discount on transfer orders.

Apr 7, 2015

As part of of our new, clear and competitive OTC service, we are now able to offer our entire Tena range in singles as well as outers.

Mar 2, 2015

At Mawdsleys, we have listened to our customers' needs and have launched a new, clear competitive OTC service.

Feb 21, 2015

Mawdsleys are delighted to welcome Penry Price to the company to head up the generic purchasing division.

Feb 20, 2015

Mawdsleys recognise that pharmacists missing out on prescription payments is a major problem, so are once again working closely with the IPF, to promote a free webinar led by experts from NHSBSA & PSNC.

Jan 26, 2015

Mawdsleys have recently announced new appointments in the business which will strengthen further the procurement capacity and support the supply chain for hospital customers.

Jan 26, 2015

Julie Clarey has joined Mawdsleys as In House Counsel for the Group.

Jan 26, 2015

November 2014 saw the start of one of the largest CMU National Contract Waves.

Jan 26, 2015

Mawdsleys are delighted that Niki Hodges has joined the company from Walsall Healthcare NHS Trust.

Jan 26, 2015

Mawdsleys have been working hard with manufacturers to provide additional choice for hospitals through new distribution agreements.

Jan 22, 2015

In April 2014, HSCIC and NHS England embarked on a Proof of Concept project in order to enable approximately 100 pharmacies access to Summary Care Records (SCR).

Jan 7, 2015

Mawdsleys have been nominated by Glenmark to distribute their CMU contracted products in England.

Jan 7, 2015

As of 1st November 2014, Mawdsleys have been nominated by Chanelle Medical to distribute their CMU contracted products in England. These products are only available via Mawdsleys and one other wholesaler.

Jan 7, 2015

As of 1st November 2014, Mawdsleys have been nominated by Typharm to distribute their CMU contracted products in England. These products are only available via Mawdsleys as a wholesale route and direct with Typharm.

Dec 22, 2014

Mawdsleys have proudly donated over 150 presents to the Key 103 Mission Christmas appeal for children living in poverty in Manchester.

Dec 9, 2014

Mawdsleys' festive season opening hours

Nov 27, 2014

Mawdsleys have been nominated as an additional wholesaler by Sinclair IS to distribute their products in England. This has been in place since August 2014.

Nov 26, 2014

As of 1st November 2014, Mawdsleys have been nominated by Genesis Pharma to distribute their CMU contracted products in England.  These products will only be available via Mawdsleys and one other wholesaler.

Oct 31, 2014

Mawdsleys Unlicensed Medicines will be present at the Neonatal and Paediatric Pharmacists Group annual exhibition and conference on 7th-9th November 2014 at the East Midlands Conference Centre in Nottingham.

Oct 1, 2014

New appointments at Mawdsleys will give pharmacies and hospitals an even more competitive wholesale service. 

Sep 18, 2014

Since 1st August 2014, the full range of Dr Reddy’s UK Ltd NHS contracted products has also been distributed via Mawdsleys to NHS hospitals within England, Scotland & Wales.

Sep 4, 2014

At MPW, Mawdsleys’ Third Party Logistics division, we have restructured to ensure the level of service given to our clients and their customers continues to be of the highest possible standard.

Jun 9, 2014

Mawdsleys are delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.

May 30, 2014

Mawdsleys and sister company Positive Solutions are working in partnership with the Independent Pharmacy Federation (IPF), to help independent pharmacists address specific challenges affecting independent pharmacy.

May 29, 2014

Mawdsleys have recently sent all our hospital customers contract notification packs with all the details they need for the new CMU contracts which started on 1st March & 1st May. As one of the nominated wholesalers for these manufacturer contracts, Mawdsleys pride ourselves, at all times possible, on being in a full stock situation from day one of new contracts waves.

May 29, 2014

Mawdsleys were praised by The Portland Hospital, the leading private hospital for children, for their commitment to ensuring an urgent unlicensed medicine was delivered to them late in the evening.

May 29, 2014

Mawdsleys have welcomed on board Aftab Raziq as the new Business Development Manager (BDM) for the Yorkshire area.

May 28, 2014

Mawdsleys have appointed Steve Bolas as National Sales Manager (Secondary Care). Steve joins us from AAH and his role will be to build upon existing customer relationships, and develop the secondary care proposition as well as looking into new markets and sectors.

Jun 6, 2019

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.

BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride developed for patients suffering from metastatic breast cancer.

The Named Patient Supply program for the EU will allow physicians early access to BP-C1 for their patients. Mawdsleys' Director of Specialty Pharma, David Regan, comments "We are pleased to be working with Meabco to add BP-C1 to our growing portfolio of oncology and rare disease medicines which Mawdsleys can make available on an early access basis to help provide new treatment options to patients with serious unmet medical needs."

Healthcare professionals can obtain further details about the BP-C1 Named Patient Supply program using the contact details below.

About BP-C1

BP-C1 is an anti-neoplastic agent with palliative properties and is based on Meabco's patented polyphenolic technology platform. BP-C1 offers a combination of immunomodulation and tumor control in one product. Usually, immunomodulation and tumor control are obtained separately by using two or more drugs.

BP-C1 has been tested in a wide range of animal trials as well as in human phase II clinical trials. The safety profile is high with very low toxicity. BP-C1 acts apoptotic, anti-proliferative and anti-angiogenic on tumor cells, while at the same time contributing to anti-cancer immune regulatory activities. Opposite to other kind of chemotherapy, BP-C1 is given as one daily intramuscular injection in the outpatient clinic or at home by a nurse or the patient himself.

BP-C1 has been tested in close to 300 breast and pancreatic cancer patients in seven countries with promising results. It is noteworthy, that more than 80% of breast cancer patients and more than 60% of pancreatic cancer patients responded to the therapy. BP-C1 is aimed at fighting the cancer combined with strengthening the body's immune system.

About Mawdsleys

Founded in 1825, Mawdsleys is a privately-owned pharmaceutical services company based in the UK with operations in Brazil and Israel. We deliver a wide range of services to both the pharmaceutical industry and healthcare sector through our main business areas which include: Named Patient Medicines (delivering global named patient programmes), Product Licensing and Market Access (In the EU, LATAM and Middle East regions), UK Wholesale (largest independent wholesaler to UK hospitals), UK Pre-wholesale (3PL and 4PL services in the UK), LUTO (healthcare communications) and Positive Solutions (pharmacy IT systems).

About Meabco A/S

Meabco A/S is a privately held biotechnology company established in 2001 researching into breakthrough cancer therapy with the vision to create new effective cancer therapy options with minimal side effects. The company has licensed all rights to two potential breakthrough cancer products which will significantly change the way cancer is being treated today and is seeking to commercialize these products over the coming years as clinical research, product registrations and physician experience develops. Meabco A/S is managed from Copenhagen with a professional Board of Directors. Strategic cGMP production sites are in place in Switzerland and Belgium ready to expand capacity as commercialization is initiated.

Helping ensure patients have access to the drugs they need, when they need them.

Mawdsleys Worldwide

Select from the following Worldwide sites...